請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42900完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 李雅玲(Ya-Ling Lee) | |
| dc.contributor.author | Tzu-Chun Chen | en |
| dc.contributor.author | 陳慈君 | zh_TW |
| dc.date.accessioned | 2021-06-15T01:28:06Z | - |
| dc.date.available | 2011-09-15 | |
| dc.date.copyright | 2009-09-15 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-07-22 | |
| dc.identifier.citation | 參考文獻
中文部份 王世禎、林萬鈺、伍德馨、丁幹 (2002).碘-131-MIBG臨床試驗,核子醫誌,15(3),129-136。 台大醫院 (2007).台大醫院兒童神經母細胞瘤整合式特別門診。2009年1月10日,取自:http://wayne.cs.nthu.edu.tw/~roland/neuroblastoma/ 台大醫院 (2008).兒童神經母細胞瘤研究會議-ANR2008參加心得。2008年1月10日,取自:http://wayne.cs.nthu.edu.tw/~roland/neuroblastoma/ 行政院衛生署 (2009).官方網站—法令規章。2009年2月18日,取自:http://www.doh.gov.tw/ 李玉嬋 (2007).醫學問題下家族治療型態的醫療諮商工作,諮商與輔導,262,44-51。 兒童癌症基金會 (2007).兒童癌症疾病介紹之神經母細胞瘤。2009年2月26日,取自:http://www.ccfroc.org.tw/child/child_affection_read.php?a_id=15 罕見疾病基金會 (2008).認識罕見疾病—分類與介紹。2009年2月26日,取自:http://www.tfrd.org.tw/rare/?PHPSESSID=7f706bd4ffb78e1ea3c351214f10a929 許文明 (2004).神經母細胞瘤生物預後因子之研究—臨床重要性及兌外科手術式之影響•博士論文,台北:國立台灣大學醫學院臨床醫學研究所。 張修豪、許文明、謝豐舟、林凱信 (2007).兒童神經母細胞瘤—被忽略的兒童期腫瘤.當代醫學34(1),855-865。 網路新聞 (2009)•新療法/癌症免疫療法新突破!陳鈴津研發20年有成。2009年5月20日,取自:http://tw.news.yahoo.com/article/url/d/a/090515/17/1jkmx.html 蔡佩真 (1998).醫療團隊照顧癌症末期病人之經驗與困難—以台中榮總為例,安寧照顧會訊,28,16-8。 蔡麗雲、謝瑞坤、楊宜霖、蘇文浩、蔡正河、張國華、方俊凱、李佩怡 (2005).某醫學中心原醫療團隊對安寧共同照謢成效評估,安寧療護雜誌,10(3),243-257。 賴怡霖 (2007).離異單親母親之母職經驗敘說研究。未發表碩士論文.南投:國立暨南國際大學輔導與諮商研究所。 盧孟佑 (2007).神經母細胞瘤治療新趨勢。台大醫網—醫學新知,12-14。 穆佩芬 (1996).現象學研究法,護理研究,4(2),195-202。 魏書娥 (2008).安寧緩和療護團隊的理念與關係—社會學的觀點,安寧療護雜誌, 13(1),66-81。 羅氏藥廠網站 (2009).藥品成份全文檢索—Roaccutane。2009年4月28日,取自:http://www.roche.com.tw/medicine/74.doc 蘇佳玲 (2008).溝通在婚姻中所扮演的角色—家庭溝通與婚姻滿意度,諮商與輔導,272,42-46。 英文部分 AAP (2003). Family Pediatrics: Report of the Task Force on the Family. Pediatrics, 111, 1541-1571. ANR (2008). Advances in Neuroblastoma Research. Retrieved Nor 12, 2008, from http://www.anrmeeting.org/ Antonovsky, A. (1987). Unraveling the Mystery of Health. San Francisco: Jossey-Bass. Antonovsky, A. (1993). The structure and properties of the sense of Coherence Scale. Social Science and Medicine, 36(6), 725-733. Antonovsky, A., & Sourani, T. (1988). Family sense of coherence and family adaptation. Journal of Marriage and the Family, 50, 79-92. Barnard, D. (1987). The viability of the concept of a primary health care team: A view from the medical humanities. Social Science and Medicine, 25(6), 741-6. Bernstein, M. L., Leclerc, J. M., Bunin, G., Brisson, L., Robison, L., & Shuster, J., et al. (1992). A population-based study of neuroblastoma incidence, survival, and mortality in North America. Journal of Clinical Oncology, 10, 323-329. Black, K., & Lobo, M. (2008). A conceptual review of family resilience factors. Journal of Family Nursing, 14(33), 33-55. Castel, V., Canete, A., Navarro, S., Garcia-Miguel, P., Melero, C., & Acha, T. et al. (2001). Outcome of high-risk neuroblastoma using a does intensity approach: Improvement in initial but not in long-term results. Med Pediatric Oncology, 37, 537-542. Castel, V., & Canete, A. (2004). A comparison of current neuroblastoma chemotherapeutics. Expert Opine Pharmacotherapy, 5, 71-80. Cecchetto, G., Mosseri, V., De Bernardi, B., Helardot, P., Monclair, T., & Costa, E., et al. (2005). Surgical risk factors in primary surgery for localized neuroblastoma: The LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. Journal of Clinical Oncology, 23(33), 8483-8489. CNCF (2008). Children’s Neuroblastoma Cancer Foundation. Retrieved Mar 10, 2008, from http://www.nbhope.org/ Cohen, M. H. (1995). The stages of the prediagnostic period in chronic life-threatening childhood illness: A process analysis. Research in Nursing and Health, 18(1), 39-48. Corrias, M. V., Haupt, R., Carlini, B., Parodi, S., Rivabella, L., & Garaventa, A., et al. (2006). Peripheral Blood Stem Cell Tumor Cell Contamination and Survival of Neuroblastoma Patients. Clinical Cancer Research, 12(19), 5680-5685. De Bernardi, B., Gerrard, M., Boni, L., Rubie, H., Cañete, A., & Di Cataldo, A., et al. (2009). Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification. Journal of Clinical Oncology, 27(7), 1034-1040. Dobrovoljski, G., Kerbl, R., Strobl, C., Schwinger, W., Dornbusch, H. J., & Lackner, H. (2003). False-Positive Results in Neuroblastoma Screening: The Parents’ View. Journal of Pediatric Hematology Oncology, 25(1), 14-18. Feeley, N., & Gottlieb, L. N. (2000). Nursing approaches for working with family strengthens and resources. Journal of Family Nursing, 6(1), 9-25. Freeman, K., O’Dell, C., & Meola, C. (2000). Issues in families of children with brain tumors. Journal of Pediatric Oncology Nursing, 27(5), 843-848. Freeman, K., O’Dell, C., & Meola, C. (2004). Childhood Brain Tumors: Parental concerns and stressors by phase of illness. Journal of Pediatric Oncology Nursing, 21(2), 87-97. Giorgi, A. (1997). Theory practice and evaluation of the phenomenological method as a qualitative research procedure. Journal of Phenomenology Psychology, 28(2), 235-260. Gurney, J. G., Tersak, J. M., Ness, K. K., Landier, Matthay, K. K., & Schmidt, M. L. (2007). Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: A report from the Children's Oncology Group. Pediatrics, 120(5), 229-36. Gurney, J. G., Ross, J. A., Wall, D. A., Bleyer, W. A., Severson R. K., & Robison L. L. (1997). Infant cancer in the U.S.: Histology-specific incidence and trends, 1973 to 1992. Journal Pediatric Hematology Oncology, 19, 428-432. Halm, M. A., Gagner, S., Goering, M., Sabo, J., Smith, M., & Zaccagnini, M. (2003). Interdisciplinary rounds: Impact on patients, families, and staff. Clinical nurse specialist, 17(3), 133-142. Hanson, S. M. (2001). Family health care nursing: An introduction. In S. M. Hanson (Ed.), Family health care nursing: Theory, practice, and research(2rd ed., pp. 3-35). Philadelphia: F.A. Davis. Hill, R. (1949). Family under stress. New York: Harper. Johns, A. (1998). Overview of bone marrow and stem cell transplantation. Journal of Intravenous Nursing, 21(6), 356-360. Letourneau, N., Drummond, J., Fleming, D., Kysela, G., McDonald, L., & Stewart, M. (2001). Supportive parents: Can intervention improve parent-child relationships? Journal of Family Nursing, 7(2), 159-187. Lincoln, Y. S. & Guba, E. G. (1985). Naturalistic inquiry. Beverly Hills, CA: Sage. Luther, S. S., Cicchetti, D., & Becker, B. (2000). The construct of resilience: A critical evaluation and guidelines for future work. Child Development, 71(3), 543-562. Manne, S., DuHamel, K., Ostroff, J., Parsons, S., Martini, D. R., & Williams, S. E., et al. (2004). Anxiety, depressive, and posttraumatic stress disorders among mothers of pediatric survivors of hematopoietic stem cell transplantation. Pediatrics, 113(6), 1700-1708. Maris, J. M., Hogarty, M. D., Bagatell, R., & Cohn, S. L. (2007). Neuroblastoma. Lancet, 369(9579), 2106-2120. Maris, J. M., & Woods, W. G. (2008). Screening for neuroblastoma: A resurrected idea? Lancet, 371(9619), 1142-1143. Matthay, K. K., Patrick Reynolds, C., Seeger, R. C., Shimada, H., Stanton Adkins, E., & Haas-Kogan, D., et al. (2009). Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A children’s oncology group study. Journal of Clinical Oncology, (27)7, 1007-1013. McCubbin, M. A. (1995). Family stress theory and the development of nursing knowledge about family adaptation. In S. L. Feetham, S. B. Meister, F. M. Bell, & C. L. Gilliss (Eds.), The nursing of family: Theory/research/education/practice (pp. 46-58). Newbury Park, CA: Sage. McCubbin, H. I., & McCubbin, M. A. (1988). Typologies of resilient families: Emerging roles of social class and ethnicity. Family Relations 37, 247–254. McCubbin, H. I., & Patterson, J. M. (1981). Broadening the scope of family strength: An Emphasis on family coping and social support. In N. Stinnett, B. Chesser & J. DeFrain (Eds.), In Family Strengths III: Roots of Well-being(pp. 177–194). University of Nebraska Press: Lincoln. McCubbin, H. I., & Patterson, J. M. (1983). The family stress process: The double ABCX model of adjustment and adaptation. Marriage and Family Review, 6(1-2), 7-37. Meleis, A. I., Douglas, M. K., Eribes, C., Shih, F., & Messias, D. K. (1996). Employed mexican women as mothers and parents: Valued, empowered and overloaded. Journal of Advanced Nursing, 23(1), 82-90. Menegaux, F., Olshan, A. F., Neglia, J. P., Pollock, B. H., & Bondy, M. L. (2004). Day care, childhood infections, and risk of neuroblastoma. American Journal of Epidemiology, 159(9), 843-51. Middlemiss, W. (2005). Prevention and intervention: Using resiliency-based multi-setting approaches and a process-orientation. Child and Adolescent Social Work Journal, 22(1), 85-103. Morris, J. K. (2002). Screening for neuroblastoma in children. Journal of Medical Screening, 9, 56. Nagi, S. (1975). Teamwork in health care in the U.S.A.: A sociological perspective. Milbank Memory Fund Quarterly, 53(4), 75-91. NANT (2009). New Advanced Neuroblastoma Therapy. Retrieved Feb 20, 2009, from http://www.nant.org/index.php Park, J. R., Eggert, A., & Caron, H. (2008). Neuroblastoma: Biology, prognosis, and treatment. Pediatric Clinics of North America, 55(1), 97-120. Patterson, J. M. (2002). Integrating family resilience and family stress theory. Journal of Marriage and Family, 64(2), 349-360. Patterson J. M. (1995). Promoting resilience in families experiencing stress. Pediatric Clinics of North America 42, 47–63. Richardson, G. E. (2002). The metatheory of resilience and resiliency. Journal of Clinical Psychology, 58(3), 307-321. Rolland, J. S. (1994). Families, illness, and disability: An integrative treatment model. New Yourk: Basic Books. Rolland, J. S., & Walsh, F. (2006). Facilitating family resilience with childhood illness and disability. Current Opinion in Pediatrics, 18, 527-538. Rutter, M. (1985). Resilience in the face of adversity: Protective factors and resistance to psychiatric disorder. British Journal of Psychiatry, 147, 598–611. Rutter, M. (1987). Psychosocial resilience and protective mechanisms. American Journal of Orthopsychiatry, 57, 316-331. Rutter, M. (1999). Resilience concepts and findings: Implications for family therapy. Journal of Family Therapy, 21(2), 119-144. Shapiro, E. R. (2002). Chronic Illness as a Family Process: A Social-Developmental Approach to Promoting Resilience. Journal of clinical psychology, 58(11), 1375-1184. Shimoni, A., & Körbling, M. (2002). Tumor cell contamination in re-infused stem cell autografts: Does it have clinical significance? Critical reviews in oncology/ Hematology, 41(2), 241-250. Stinnett, N., & DeFrain, J. (1985). Secret of strong families. Boston: Little, Brown. Stoppelbein, L., & Greening, L. (2007). Brief report: The risk of posttraumatic stress disorder in mothers of children diagnosed with pediatric cancer and type I diabetes. Journal of Pediatric Psychology, 32(2), 223–229. TNS (2009). The Neuroblastoma Society. Retrieved Feb 20, 2009, from http://www.nsoc.co.uk/ Tsubono, Y., & Hisamichi, S. (2002). A halt to Neuroblastoma screening in Japan. The New England Journal of Medicine, 350(19), 2010-2011. Walsh, F. (1996). The concept of family resilience: Crisis and challenge. Family Process, 35, 261–281. Walsh, F. (1998). Strengthening family resilience. New York: Guilford Press. Walsh, F. (2002). A family resilience framework: Innovative practice applications. Family Relations, 51(2), 130-137. Walsh, F. (2003). Family resilience: A framework for clinical practice. Family Process, 42(1), 1-18. White, N., Richter, J., Koeckeritz, J., Munch, K., & Walter, P. (2004). “Going forward”: Family resiliency in patients on hemodialysis. Journal of Family Nursing, 10(3), 357-378. Winstein, J. L., Katzenstein, H. M., & Cohn, S. L. (2003). Advances in the diagnosis and treatment of neuroblastoma. Oncologist, 8, 287-292. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42900 | - |
| dc.description.abstract | 神經母細胞瘤(Neuroblastoma)是嬰兒最常見的固態腫瘤也是孩童第二常見的顱部惡性腫瘤,其高風險群的五年總存活率只有三成左右。本研究目的在探討家庭面對罹患罕見疾病神經母細胞瘤高風險群(High-risk group)患孩時的完整患病經驗與治療過程。運用質性研究之Giorgi (1997)的現象學研究法,以深度訪談與參與式觀察進行資料收集,採立意取樣,從主要照顧者的角度及觀點瞭解其家庭經驗,共訪得八位患孩的主要照顧者,資料達飽和。
研究結果發現,家庭的患病經驗與治療過程共涵蓋了七個範疇,可以依「時間序列」及「資源運用」兩個方面分析;前者包括四個階段性的治療過程,其為:「對剛發病的震撼與衝擊歷程」、「對疾病特性的不確定感」、「對階段性治療照護與學習經驗的歷程」及「對療程結束後的反應」;後者為三個家庭運用的資源協助,包括:「對家庭凝聚力與扶持的韌力表現」、「對醫療團隊的協助與期盼」及「對社會資源的需求與期盼」。 經由深入討論本研究的結果,發現有十項家庭韌力因子支持其家庭功能,包括了勇氣、家庭調整、學習、正向思考、靈性需求、比較、家庭溝通、支持系統、家庭期許及一致性的做法。本研究的結論是「家庭韌力」存在於每一個家庭中,當小孩罹患神經母細胞瘤疾病時,家庭會配合著臨床醫療團隊,依循著階段性治療療程及運用身旁資源幫助患孩,陪著患孩一同前進,並運用家庭的力量克服歷程中所會遇到的問題與困難。 台灣地區神經母細胞瘤的整合性治療與醫療照護團隊尚處於發展階段,本研究結果可以提供臨床專業醫療人員、社會支持團體及家庭協助者在幫助這纇病患及家庭時的參考依據,進一步發展「以家庭為中心」的協助與醫療照護指引,以協助神經母細胞瘤家庭韌力的發揮、調適並能正向地渡過整段醫療歷程。 | zh_TW |
| dc.description.abstract | Neuroblastoma is the most common solid tumor of infancy and the second most common extracranial malignant tumor of childhood, and its five-year overall survival rate in high-risk group approximated about 30%. The purpose of this qualitative study was to explore the illness experience and treatment process of a family with a high-risk group neuroblastoma child. A purposive sample of eight caregivers was selected to the main objective by the methods of in-depth interviews and participate-observation. Using the Giorgi (1997) phenomenological analysis method, data were analyzed and integrated to seven themes. The results of this study show that the family experiences of children undergoing treatment to class with two parts including time processes and resources. The former includes that the shockness reaction and the impact experience when the illness break out in the first stage, the uncertainty of the characterization of this disease, the experiences of the treatments course and study process, and the responses after the courses of treatments, and the later includes that the supports from family cohesion and family resilience, the assistances and expectations from health care team, and the needs and expectations from the social resource.
There are ten resilience factors derived from the discussion of the results that included courage、family adjustment、learning、positive outlook、spirituality、compare、family communication、support systems、family expectance and family member accord. The results show that family resilience exists in every family, that is, every family can overcome all of the adversity and cross it hardly. Owing to the fact that the integrated treatment and the Health-Care Team are in the developing stage in Taiwan, the results of the study can promotes health professionals implement appropriate interventions as well as providers a working outline for social workers. In addition, these may be not only referenced in the guide of family center care but also helped the development of the family resilience, which can help the family to cross the whole treatment processes. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T01:28:06Z (GMT). No. of bitstreams: 1 ntu-98-R96426022-1.pdf: 3171397 bytes, checksum: 7c34e32eca64276866bce528f2fad0ad (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | 致謝……………………………………………………………i
中文摘要…………………………………………………… ii 英文摘要……………………………………………………iii 目錄……………………………………………………………v 圖表目錄……………………………………………………vii 第一章 緒論 第一節 研究背景與動機……………………………………1 第二節 研究目的……………………………………………3 第三節 研究問題的陳述……………………………………4 第四節 名詞界定……………………………………………5 第二章 文獻探討 第一節 神經母細胞瘤………………………………………6 第二節 「治療團隊」在神經母細胞瘤疾病上之意義……13 第三節 「家庭韌力」與臨床照護之關係…………………16 第三章 研究方法與進行步驟 第一節 研究設計……………………………………………20 第二節 研究流程……………………………………………21 第三節 研究對象及地點……………………………………22 第四節 研究資料收集與紀錄………………………………23 第五節 前驅研究結果………………………………………25 第六節 資料分析過程與記錄………………………………31 第七節 嚴謹度………………………………………………32 第八節 倫理考量……………………………………………34 第四章 研究結果 第一節 受訪個案家庭基本資料………………………………35 第二節 訪談資料分析結果……………………………………42 第五章 討論 第一節 研究家庭基本資料之分析與討論………………………62 第二節 神經母細胞瘤家庭依時間序列的階段性治療過程……63 第三節 神經母細胞瘤家庭的資源協助面………………………71 第四節 研究家庭之家庭韌力表現………………………………78 第六章 結論與建議 第一節 結論………………………………………………………86 第二節 建議………………………………………………………87 第三節 研究限制…………………………………………………89 參考文獻 中文部份……………………………………………………………90 英文部分……………………………………………………………91 附錄 附錄一 TPOG- N2002 神經母細胞瘤高風險群治療流程圖………98 附錄二 TPOG- N2002 高風險群一之治療療程……………………99 附錄三 TPOG- N2002 高風險群二(自體幹細胞移植)之治療療程……………100 附錄四 TPOG- N2002 高風險群二(非自體幹細胞移植)之治療療程…………101 附錄五 臺大醫院研究倫理委員會通過公文 …………………102 附錄六 臨床試驗受試者說明及同意書……………………………104 附錄七 研究家庭基本資料表……………………………………108 附錄八 訪談指引…………………………………………………109 圖表目錄 表2-1 國際神經母細胞瘤分期表……………………………………7 表2-2 兒童神經母細胞瘤危險分群表………………………………8 表3-1 前驅研究患孩基本資料表……………………………………25 表3-2 前驅研究個案基本資料表……………………………………25 表3-3 前驅研究家庭狀況基本資料表………………………………26 表3-4 神經母細胞瘤患病家庭於治療過程中關注點初步統整與分類表………28 表4-1 患孩基本資料表………………………………………………35 表4-2 個案基本資料表………………………………………………36 表4-3 家庭狀況基本資料表…………………………………………36 表4-4 研究結果主題、次主題與類別一覽表………………………42 表5-1 神經母細胞瘤家庭之家庭功能與家庭韌力之表現…………78 表5-2 神經母細胞瘤家庭功能表現及韌力因子的分析與舉例……80 表5-3 家庭韌力表現與發揮統整表…………………………………82 表5-4 本研究家庭之韌力表現與可提供之護理協助………………83 圖3-1 研究流程圖……………………………………………………21 | |
| dc.language.iso | zh-TW | |
| dc.subject | 醫療團隊 | zh_TW |
| dc.subject | 質性研究 | zh_TW |
| dc.subject | 神經母細胞瘤 | zh_TW |
| dc.subject | 家庭韌力 | zh_TW |
| dc.subject | neuroblastoma | en |
| dc.subject | qualitative research | en |
| dc.subject | family resilience. | en |
| dc.subject | health care team | en |
| dc.title | 那彩虹橋的韌性—神經母細胞瘤家庭之患病經驗與治療過程 | zh_TW |
| dc.title | Resilience of the Rainbow Bridge—The Illness Experience and Treatment Process of Families with a Neuroblastoma Child | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 穆佩芬(Pei-Fan Mu),許文明(Wen-Ming Hsu) | |
| dc.subject.keyword | 質性研究,神經母細胞瘤,醫療團隊,家庭韌力, | zh_TW |
| dc.subject.keyword | qualitative research,neuroblastoma,health care team,family resilience., | en |
| dc.relation.page | 109 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2009-07-22 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 護理學研究所 | zh_TW |
| 顯示於系所單位: | 護理學系所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 未授權公開取用 | 3.1 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
